Tag: remdesivir
Rumsfeld Shady Heritage in Pandemic: GILEAD’s Intrigues with WHO & Wuhan...
«You will only observe with your eyes and see the punishment of the wicked. If you say, “The Lord is my refuge”, and you...
Supply for Antiviral Remdesivir is Meeting U.S. Demands
Beginning October 1, Gilead will be responsible for distributing Veklury in the United States upon conclusion of the previous distribution agreement with the U.S. Federal government.
Antiviral Remdesivir Approved for Earlier Use For COVID-19 Patients
Gilead’s Investigational Antiviral Veklury® (Remdesivir) Receives U.S. Food and Drug Administration Emergency Use Authorization for the Treatment of Patients With Moderate COVID-19
Gilead To Start Trials of Inhaled Version of Remdesivir
So far, randomized controlled trials of remdesivir have been evaluating its safety and efficacy in hospitalized patients.
Government’s Supply of Antiviral Remdesivir Runs Out at End of June
Whatever the supply may be, there may not be enough for everyone who may need it."
Remdesivir Benefits Hospitalized Severe COVID-19 Patients
The median time to recovery was 11 days for patients treated with the drug compared with 15 days for those who received the placebo.
Gilead Working on Easier-To-Use Versions of Antiviral Remdesivir
Gilead is also seeking to treat the virus earlier.
Antiviral Remdesivir Improves Time to Recovery from COVID-19
Ultimately, the findings support remdesivir as the standard therapy for patients hospitalized with COVID-19 and requiring supplemental oxygen therapy, according to the authors.
NIH: Begins Clinical Trial of Antiviral Remdesivir and Baricitinib (Anti-Inflammatory) For...
“We now have solid data showing that remdesivir diminishes to a modest degree the time to recovery for people hospitalized with COVID-19,” said NIAID Director Anthony S. Fauci, M.D.
NIH Study: Antiviral Remdesivir Prevents COVID-19 Progression in Monkeys
Study Supports Clinical Testing Under Way Across U.S.